Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Apple
AAPL
|
+$9.29B |
| 2 |
NVIDIA
NVDA
|
+$1.77B |
| 3 |
Broadcom
AVGO
|
+$1.59B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 5 |
T-Mobile US
TMUS
|
+$1.48B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$3.16B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.92B |
| 3 |
Amazon
AMZN
|
+$2.22B |
| 4 |
Microsoft
MSFT
|
+$2.14B |
| 5 |
Merck
MRK
|
+$1.72B |
Sector Composition
| 1 | Technology | 24.16% |
| 2 | Healthcare | 19.43% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Coinbase
COIN
$81.9B
| $2.16M | ﹤0.01% |
9,726
-2,920
| -23% | -$649K |
|
1402
Ocular Therapeutix
OCUL
$2.22B
| $2.15M | ﹤0.01% |
314,554
+43,636
| +16% | +$298K |
|
1403
Wave Life Sciences
WVE
$1.19B
| $2.14M | ﹤0.01% |
428,311
+29,212
| +7% | +$146K |
|
|
FINV
1404
FinVolution Group
FINV
$1.98B
| $2.14M | ﹤0.01% |
447,931
-29,163
| -6% | -$139K |
|
1405
WEC Energy
WEC
$34.6B
| $2.13M | ﹤0.01% |
27,162
-1,270
| -4% | -$99.6K |
|
1406
Praxis Precision Medicines
PRAX
$843M
| $2.13M | ﹤0.01% |
51,513
+11,948
| +30% | +$494K |
|
1407
Viking Therapeutics
VKTX
$2.84B
| $2.11M | ﹤0.01% |
39,835
+4,664
| +13% | +$247K |
|
1408
Okta
OKTA
$16.5B
| $2.1M | ﹤0.01% |
22,478
+13,515
| +151% | +$1.27M |
|
1409
Summit Therapeutics
SMMT
$14B
| $2.09M | ﹤0.01% |
268,152
-29,468
| -10% | -$230K |
|
1410
Harley-Davidson
HOG
$3.77B
| $2.09M | ﹤0.01% |
+62,197
| New | +$2.09M |
|
1411
Harrow
HROW
$1.45B
| $2.08M | ﹤0.01% |
99,567
+7,881
| +9% | +$165K |
|
1412
Vanda Pharmaceuticals
VNDA
$266M
| $2.07M | ﹤0.01% |
365,758
-70,009
| -16% | -$396K |
|
1413
Thomson Reuters
TRI
$79.2B
| $2.04M | ﹤0.01% |
12,106
+2,136
| +21% | +$360K |
|
1414
Nutanix
NTNX
$20.3B
| $2.03M | ﹤0.01% |
35,724
+27,257
| +322% | +$1.55M |
|
1415
Imperial Oil
IMO
$45.6B
| $2.03M | ﹤0.01% |
29,771
-157,215
| -84% | -$10.7M |
|
1416
Krystal Biotech
KRYS
$4.09B
| $2.02M | ﹤0.01% |
11,020
+1,712
| +18% | +$314K |
|
1417
CAE Inc
CAE
$8.4B
| $2.02M | ﹤0.01% |
108,924
-82,428
| -43% | -$1.53M |
|
|
DCBO
1418
Docebo
DCBO
$890M
| $2.02M | ﹤0.01% |
+52,310
| New | +$2.02M |
|
1419
Corebridge Financial
CRBG
$18B
| $2.02M | ﹤0.01% |
69,259
-2,056,324
| -97% | -$59.9M |
|
1420
Phibro Animal Health
PAHC
$1.67B
| $1.97M | ﹤0.01% |
117,346
-47,925
| -29% | -$804K |
|
1421
MiMedx Group
MDXG
$1.05B
| $1.97M | ﹤0.01% |
283,813
+16,621
| +6% | +$115K |
|
1422
Voyager Therapeutics
VYGR
$222M
| $1.95M | ﹤0.01% |
246,992
+42,963
| +21% | +$340K |
|
1423
Stoke Therapeutics
STOK
$1.21B
| $1.94M | ﹤0.01% |
143,636
+285
| +0.2% | +$3.85K |
|
1424
Y-mAbs Therapeutics
YMAB
$390M
| $1.94M | ﹤0.01% |
160,444
+14,141
| +10% | +$171K |
|
1425
iShares China Large-Cap ETF
FXI
$6.83B
| $1.93M | ﹤0.01% |
74,234
-18,887
| -20% | -$491K |
|